viernes, 24 de enero de 2025

SKIN & INFLAMMATORY CONDITIONS

SKIN & INFLAMMATORY CONDITIONS Key Target for Seborrheic Dermatitis Highlighted Inflammation Now the Key Target for Seborrheic Dermatitis Ted Bosworth https://www.medscape.com/viewarticle/inflammation-now-key-target-seborrheic-dermatitis-2025a100005x?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790 January 06, 2025 Allergic Contact Dermatitis: New Culprits Allergic Contact Dermatitis: New Culprits Stéphanie Lavaud https://www.medscape.com/viewarticle/allergic-contact-dermatitis-new-culprits-2024a1000ok0?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790 Topical Ruxolitinib: Practice Essential ruxolitinib topical (Rx) https://reference.medscape.com/drug/opzelura-ruxolitinib-topical-4000177?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790 Long-Term Budesonide Shows Sustained Efficacy in EoE Long-Term Budesonide Shows Sustained Efficacy in Eosinophilic Esophagitis Edited by Vinod Rane https://www.medscape.com/viewarticle/long-term-budesonide-shows-sustained-efficacy-eosinophilic-2025a10000jk?ecd=mkm_ret_250124_mscpmrk_allergy_top-content_etid7181790&uac=148436CN&impID=7181790 January 10, 2025

No hay comentarios:

Publicar un comentario